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TECH HINTS 
MICROFILTRATION FOR CAPILLARY 
TUBE USE 
Mary N. Crawford 
Capillary tube testing requires reagents free of par- 
ticulate matter and excessive lipids. It is difficult to 
filter, by the usual methods, the small amounts that 
are suitable for this technique. A microfilter that can 
Figure 1. Improved microfilter for chrification of 
sera for capillary tube testing* 
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* With this apparatus, it is possible to kilter 2 - 3 drops of serum. For almost 
total recovery o f  serum. I - 2 drops of saline o r  6%, albumin should 
be spun through first and then removed. 
be assembled rapidly (2 min) and has proved useful 
for this purpose, is described. A Tampax sup(R) tampon 
(Tam Brands, Inc., Lake Success, NY) should be pulled 
apart and enough fibers torn off to pack down to a 
0.6 cm (114 inch) amount in a small 4.7 cm pipette 
filter tip (Electra Tips 620/650, Medical Laboratory 
Automation, Inc., Mt. Vernon, NY) from which the last 
0.6 cm has been cut off to enhance the flow. Approx- 
imately 1 - 2 cm of Seitz fibers should be tamped down 
on top of the Tampax sup(R) fibers. These fibers can be 
taken from the leftover Seitz material surrounding 
punched out pads in commercial filtration kits (11 or 
22 mm filter discs made for the 2 or 25 mL sized 
Boerner Centrifugal Filters distributed by Arthur H. 
Thomas Co.). The microfilter is then inserted into a 
400 L polyethylene microcentrifuge tube (MC-1 
from Analytical Lab Accessories), and two or more 
drops of serum are put into the microfilter pipette tip. 
This whole assembly is put into a 1 mL Fisher plastic 
tube for centrifugation. A hard spin, 7000 rpm for 5 
min, is necessary for passage of reagents through the 
combination of fibers, therefore a Fisher type cen- 
trifuge is helpful. For virtually total recovery of 
reagents, two drops of saline or 6 percent bovine 
albumin may first be spun through the microfilter and 
then completely removed from the microcentrifuge 
tube before centrifugation of the serum. 
This procedure is depicted in Figure 1. 
Mary N. Crawford, MU, Pearson C. Cummirr Memorial 
Iaboratory, 125 Ashwood Road, Villanova, PA 19085. 
COMMUNICATIONS 
To the Editor: 
Hooray for John Judd! By condemning' the 
description of exceptionally powerful examples of anti- 
N as anti-’N’, he has struck a blow for clarity in com- 
munication between scientists. 
If we are to succeed in understanding each other, 
it is important that we do not allow ourselves to lapse 
into jargon, or adopt loose terminology that departs 
from established conventions. The antibodies described 
in the reports by both Guizzo and Meadows2 and 
Kosanke and Behzad sup(3) were plainly examples of anti- 
N possessing a sufficient reserve of potency to give 
detectable agglutination with cells lacking N but 
possessing ‘N’: To call these antibodies anti-’N’ is surely 
similar to calling anti-A, anti-A sub(2) because it agglutinates 
A sub(2) (as well as A sub(1)) cells, or anti-D, anti-D sup(u) because it 
is capable of detecting D sup(u) (as well as D). Are we en- 
titled to call anti-A,B anti-A,? How about anti-i for an 
example of anti-I powerful enough that it requires dilu- 
tion to show no agglutination of umbilical cord cells? 
Can we think of anti-Fy sup(b) as anti-Fy sup(x) if it detects the 
weak Fy sup(b) supposedly produced by Fy sup(x)? 
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Joanne Kosanke has a point, I suppose. sup(4) Maybe the 
problem originates with those who persist in think- 
ing of ‘N’ as an antigen distinct from N. It is an antigen, 
to be sure; but the antibody produced in response to 
it is indistinguishable from that produced in response 
to N–quite understandably, since the structures of N 
and ‘N’ are identical, so far as we can tell. If it turns 
out that there is a difference that enables ‘N’ to pro- 
duce its own specific immune response, then the anti- 
‘N’ we can expect to see will not show the reactions 
described in the two papers mentioned above. If anti- 
‘N’ does exist, it will be very hard to distinguish from 
anti-U, since it will be nonreactive with NS sup(u)/NS sup(u) and 
MS sup(u)/NP sup(u) cells, as well as MP sup(u)/MS sup(u) cells. It will be 
quite useful, actually, because it will facilitate the 
recognition of U-negative bloods that result from 
homozygosity for the Dantu gene (or heterozygosity 
of Dantu with S sup(u)), as Dantu produces enhanced 
expression of ‘N’, while S sup(u) produces none. It will no 
doubt enable us to make other distinctions we do not 
even dream of at present. Until then, though, we must 
continue to realize that anti-N sees no difference be- 
tween N and ‘N’, except in terms of strength of 
expression. If there is more ‘N’ than usual on a sample 
of N-negative cells, then they are apt to type as N +  . 
And if anti-N is exceptionally potent, as it commonly 
is when produced by an S - s - person, it may require 
considerable dilution before showing clearcut negative 
reactivity with red cells possessing ‘N’ but lacking N. 
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CLASSIFIED 
SBB Program Coordinated/Reference Lab Super- 
visor: One of the original SBB schools in the coun- 
try is seeking a highly qualified candidate to manage 
its very vital and active program. MT(ASCP)SBB with 
supervisory experience required. Masters degree in 
education or a related field preferred. Responsible for 
coordination of all education functions of the Blood 
Bank and direction of a busy AABB accredited 
reference lab of a 1000-bed university affiliated 
hospital. Faculty position with School of Allied Health 
Sciences. Salary negotiable. CV to or contact: Valerie 
Jackson, MS, AIMLS, Technical Director, Blood Bank, 
University of Texas Medical Branch, Galveston, TX 
77550, (409) 761-1524. EOE/M/F/H. 
Immunohematologist, Specialist in Blood Bank- 
ing: A challenging opportunity for the motivated 
individual to work in an advanced red cell reference 
laboratory. Desirable qualities include the following: 
sophisticated red cell problem solving skills, 
knowledge of blood group genetics, oral and written 
communication skills, interpersonal skills, and creativ- 
ity. Teaching skills a plus. Accountabilities include 
writing and presenting a minimum of one paper 
annually at the state, regional, or national level. This 
is a unique opportunity for the right person to work 
with a peer group of five individuals. Qualifi- 
cations: MT(ASCP)SBB (or equivalent). Salary: 
$24,500-37,500. On-call one week in five with 
excellent on-call compensation. Contact: Delores 
Mallory, MT(ASCP)SBB, Director, Laboratory Services, 
American Red Cross Medical Operations, 15601 Crabbs 
Branch Way, Rockville, MD 20855-2736, (301) 
738-0505. 
Donor Resources Director: Combine your 
managerial training and experience to work with the 
friendliest people in Tampa-OUR DONORS. Your 
responsibilities include planning, organizing, and 
directing donor recruitment programs for mobile 
operations and donor centers, 57,000 units annually. 
Bachelors degree in business or marketing or other 
related field, with 5 years experience in sales, public 
relations, or education; 3 of which should be 
administrative/supervisory. Contact: Wendi R. Watson, 
Personnel Supervisor, at (813) 876-5433, ext. 205, or 
send resume to: Southwest Florida Blood Bank, Inc., 
PO Box 2125, Tampa, FL 33601-2125. EOE. 
Blood Processing Laboratory Supervisor: 
Experienced donor blood processing laboratory super- 
visor, MT(ASCP)SBB required, for progressive institu- 
tion, one of the largest regionalized compatibility 
systems in this country. Competitive salary; benefits 
program allows you to earn up to 25 paid days off your 
first year Contact: Wendi R. Watson, Personnel Super- 
visor, at (813) 876-5433, ext. 205, or send resume with 
salary requirements to: Southwest Florida Blood Bank, 
Inc., PO Box 2125, Tampa, FL 33601-2125. EOE. 
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